Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marvel Biosciences Corp (TSE:MRVL)
TSXV:MRVL
Holding TSE:MRVL?
Track your performance easily
MRVL Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.06 - C$0.19
Previous CloseC$0.16
Volume11.00K
Average Volume (3M)62.27K
Market Cap
C$7.17M
Enterprise ValueC$8.45M
Total Cash (Recent Filing)C$217.69K
Total Debt (Recent Filing)C$1.50M
Price to Earnings (P/E)―
Beta-0.07
Next Earnings
Mar 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding44,790,000
10 Day Avg. Volume38,796
30 Day Avg. Volume62,273
Standard Deviation0.18
R-Squared0.02
Alpha0.00976
Financial Highlights & Ratios
Price to Book (P/B)-2.67
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Marvel Biosciences Corp News
PremiumCompany Announcements
Marvel Biosciences Reveals Promising Study Results
PremiumCompany Announcements
Marvel Biosciences Advances Alzheimer’s Research with New Grant
PremiumCompany Announcements
Marvel Biosciences’ MB204 Shows Promise in Rett Syndrome
PremiumCompany Announcements
Marvel Biosciences’ MB204 Shows Promise in Autism Study
PremiumCompany Announcements
Marvel Biosciences Tests New Treatment for Fragile X SyndromePremiumCompany Announcements
Marvel Biosciences Grants Stock Options to LeadershipPremiumCompany Announcements
Marvel Biosciences Expands Rett Syndrome Drug Research
PremiumCompany Announcements
Marvel Biosciences Raises Funds for Biomedical ResearchOptions Prices
Currently, No data available
---
Ownership Overview
MRVL FAQ
What was Marvel Biosciences Corp’s price range in the past 12 months?
Marvel Biosciences Corp lowest stock price was C$0.06 and its highest was C$0.19 in the past 12 months.
What is Marvel Biosciences Corp’s market cap?
Currently, no data Available
When is Marvel Biosciences Corp’s upcoming earnings report date?
Marvel Biosciences Corp’s upcoming earnings report date is Mar 26, 2025 which is in 94 days.
How were Marvel Biosciences Corp’s earnings last quarter?
Currently, no data Available
Is Marvel Biosciences Corp overvalued?
According to Wall Street analysts Marvel Biosciences Corp’s price is currently Overvalued.
Does Marvel Biosciences Corp pay dividends?
Marvel Biosciences Corp does not currently pay dividends.
What is Marvel Biosciences Corp’s EPS estimate?
Marvel Biosciences Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marvel Biosciences Corp have?
Marvel Biosciences Corp has 44,786,232 shares outstanding.
What happened to Marvel Biosciences Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Marvel Biosciences Corp?
Currently, no hedge funds are holding shares in TSE:MRVL
---
Marvel Biosciences Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
100.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-47.41%
Trailing 12-Months
Company Description
Marvel Biosciences Corp
Alphanco Venture Corp is a capital pool company based in Canada. It proposes to identify and evaluate corporations, businesses or assets for acquisition and once identified and evaluated to negotiate an acquisition or participation subject to receipt of regulatory and shareholder approval, as applicable.
---
Technical Analysis
---